Caprock Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.86M | Buy |
|
|||||
|
2025
Q1 | $776K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $220K | Sell |
|
|||||
|
2022
Q2 | $274K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $437K | Buy |
|
|||||
|
2021
Q2 | $336K | Buy |
|
|||||
|
2021
Q1 | $259K | Buy |
|
|||||
|
2020
Q4 | $213K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $220K | Sell |
|
|||||
|
2019
Q3 | $235K | Hold |
|
|||||
|
2019
Q2 | $252K | Hold |
|
|||||
|
2019
Q1 | $258K | Sell |
|
|||||
|
2018
Q4 | $206K | Hold |
|
|||||
|
2018
Q3 | $245K | Hold |
|
|||||
|
2018
Q2 | $204K | Sell |
|
|||||
|
2018
Q1 | $211K | Hold |
|
|||||
|
2017
Q4 | $208K | Sell |
|
|||||
|
2017
Q3 | $373K | Buy |
|